Expressive writing
BehavioralWriting as therapeutic intervention
NCT Number: NCT00233142
This study will determine whether the psychological benefits of expressive writing extend to diabetic patients, how long the benefits will last, and whether additional expressive writing "booster" sessions will lead to greater and more sustained improvement in diabetes symptoms and well-being.
Looking for future studies?
Notify Me25 year–75 year
All sexes
Interventional
Phase 2
State University of New York Medical University, Syracuse, New York, United States
Diabetes is one of the leading causes of blindness, kidney failure, and nontraumatic lower extremity amputation in the United States. Conditions such as stress and depression have been shown to worsen diabetic symptoms. Data indicate that expressive writing (an activity during which individuals deal with stressful experiences by writing about them on paper) has beneficial effects on psychological and physiological outcomes. This study will determine whether diabetes patients can benefit from expressive writing. This study will also determine the duration of the benefits and the effectiveness of booster sessions in improving their diabetic symptoms.
Participants will be randomly assigned to engage in expressive writing or neutral writing for 18 months. Participants in the expressive writing group will write about traumatic or stressful events; participants in the neutral writing group will write about neutral topics that do not affect them emotionally. Some participants in the expressive writing group will receive an additional 4 months of booster sessions of expressive writing. All participants will undergo interviews, blood collection, physical exams and complete clinical scales on their disease status, quality of life, and psychological well-being; these assessments will occur at study entry, every 4 months during the study, and at the end of the study.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Writing as therapeutic intervention
Non-expressive writing
Time frame: baseline, 4 months, 8 months, 12 months, and 16 months
Time frame: baseline, 4 months, 8 months, 12 months, and 16 months
Time frame: baseline, 4 months, 8 months, 12 months, and 16 months
Time frame: baseline, 4 months, 8 months, 12 months, and 16 months
Time frame: baseline, 4 months, 8 months, 12 months, and 16 months
Time frame: baseline, 4 months, 8 months, 12 months, and 16 months
Syracuse University
Other
Expressive Writing: Complementary Treatment for Diabetes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06248190
Asthma, Behavior
Pietermaritzburg, KwaZulu-Natal, South Africa
View Trial DetailsNCT01327404
Behavior, Behavioral Symptoms
Chicago, Illinois, United States
View Trial DetailsNCT01931644
ADD/ADHD, Abnormalities, Multiple
Los Angeles, California, United States
View Trial DetailsNCT05140551
Anxiety, Anxiety Disorders
London, Other, United Kingdom
View Trial Details